Literature DB >> 10430179

Increased expression of the distal, but not of the proximal, Gata1 transcripts during differentiation of primary erythroid cells.

A M Vannucchi1, S Linari, C S Lin, M J Koury, M C Bondurant, A R Migliaccio.   

Abstract

Gata1 is expressed from either one of two alternative promoters, the erythroid (proximal to the AUG) and the testis (distal to the AUG) promoter, both used by hemopoietic cells. To clarify the role of the distal and proximal Gata1 transcripts in erythroid differentiation, we determined by specific reverse transcriptase-polymerase chain reactions their relative levels of expression during the differentiation of erythroid precursors purified from the spleen of mice treated with phenylhydrazine (PHZ) or infected with the anemia-inducing strain of the Friend virus (FVA cells). PHZ cells are erythroid precursors that progress in vivo to erythroblasts in 3 days. Both PHZ and FVA cells synchronously proliferate and differentiate in vitro in the presence of erythropoietin (EPO). The levels of total and of distal, but not of proximal, Gata1 transcripts increased by five- to eightfold during in vivo and in vitro differentiation of FVA and PHZ cells. The increase in expression was temporally associated with an increase in the expression of Eklf, Scl, and Nfe2, three genes required for erythroid differentiation, and preceded by 24 h the repression of Gata2 and Myb expression. The day 1 PHZ cells that survived 18 h in the absence of EPO do not express globin genes and express detectable levels of distal but not of proximal Gata1 transcripts. These cells activate the expression of the globin genes within 2 h when exposed to EPO. Therefore, during erythroid differentiation of primary cells, increased expression of distal Gata1 transcripts underlies the increase in the expression of total Gata1 associated with the establishment of the erythroid differentiation program.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430179     DOI: 10.1002/(SICI)1097-4652(199909)180:3<390::AID-JCP10>3.0.CO;2-K

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.

Authors:  Stephane Wong; Jami McLaughlin; Donghui Cheng; Kevin Shannon; Lorraine Robb; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

2.  High frequency of alternative first exons in erythroid genes suggests a critical role in regulating gene function.

Authors:  Jeff S Tan; Narla Mohandas; John G Conboy
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

3.  The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor.

Authors:  Barbara Ghinassi; Massimo Sanchez; Fabrizio Martelli; Giovanni Amabile; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin; Anna Rita Migliaccio
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

4.  Alternative pre-mRNA splicing switches modulate gene expression in late erythropoiesis.

Authors:  Miki L Yamamoto; Tyson A Clark; Sherry L Gee; Jeong-Ah Kang; Anthony C Schweitzer; Amittha Wickrema; John G Conboy
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

5.  Differential gene expression during terminal erythroid differentiation.

Authors:  S Koury; S Yarlagadda; K Moskalik-Liermo; N Popli; N Kim; C Apolito; A Peterson; X Zhang; P Zu; J Tamburlin; D Bofinger
Journal:  Genomics       Date:  2007-08-31       Impact factor: 5.736

6.  The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis.

Authors:  Lilian Varricchio; Anna Rita Migliaccio
Journal:  Am J Blood Res       Date:  2014-12-15

Review 7.  GATA1 mutations in red cell disorders.

Authors:  Te Ling; John D Crispino
Journal:  IUBMB Life       Date:  2019-10-25       Impact factor: 3.885

8.  GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant.

Authors:  Anna Rita Migliaccio; Rosa Alba Rana; Massimo Sanchez; Rodolfo Lorenzini; Lucia Centurione; Lucia Bianchi; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.